Chu, N R <br/><br/>
Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette-Guérin (BCG) hsp65 and HPV16 E7.  [electronic resource] 

 -  Clinical and experimental immunology  Aug 2000 
 - 216-25 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0009-9104 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2249.2000.01293.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anus Neoplasms--prevention & control<br/>Bacterial Proteins<br/>CD4-Positive T-Lymphocytes--immunology<br/>CD8-Positive T-Lymphocytes--immunology<br/>Chaperonin 60<br/>Chaperonins--genetics<br/>Female<br/>Genes, Viral<br/>Humans<br/>Immunization<br/>Immunotherapy<br/>Lung Neoplasms--genetics<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Mycobacterium bovis--genetics<br/>Neoplasm Transplantation<br/>Oncogene Proteins, Viral--genetics<br/>Papillomaviridae--genetics<br/>Papillomavirus E7 Proteins<br/>Recombinant Fusion Proteins--immunology<br/>Spleen--immunology<br/>T-Lymphocytes, Cytotoxic--immunology<br/>Tumor Cells, Cultured--transplantation<br/>Uterine Cervical Neoplasms--prevention & control<br/>Vaccines, Synthetic--therapeutic use<br/>Viral Structural Proteins--genetics<br/>Viral Vaccines--therapeutic use